Exocrine Pancreatic Insufficiency
Exocrine pancreatic insufficiency (EPI) is a condition in which the pancreas fails to produce sufficient digestive enzymes to break down food properly. Without adequate enzymes, fats, proteins, and carbohydrates pass through the gut largely undigested, leading to poor nutrition and discomfort.
Medicine used to treat Exocrine Pancreatic Insufficiency
What it looks and feels like
The most telling sign is steatorrhoea: loose, pale, greasy stools that are difficult to flush and have a strong odour. Weight loss despite eating normally, bloating after meals, and cramping are common. Nutritional deficiencies, particularly of fat-soluble vitamins A, D, E, and K, can develop over time and cause fatigue or bone pain.
The role of enzyme replacement
Treatment centres on replacing the missing enzymes. Pancrelipase is the standard enzyme preparation, taken with each meal and snack to restore normal digestion. It is the main option under digestive health for EPI and works by supplying lipase, amylase, and protease directly in the gut where they are needed. Dose is adjusted to stool response; many people see a clear improvement in stool consistency and weight within weeks.
Underlying causes, chronic pancreatitis, cystic fibrosis, or prior pancreatic surgery, should be addressed alongside enzyme therapy. Anyone with new or worsening symptoms, unexplained significant weight loss, or persistent pain should be reviewed by a doctor.